应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AEZS 依特钠
交易中 05-03 15:37:13 EDT
7.74
-0.42
-5.15%
最高
8.35
最低
7.74
成交量
1.87万
今开
7.80
昨收
8.16
日振幅
7.46%
总市值
939.61万
流通市值
938.19万
总股本
121.40万
成交额
14.81万
换手率
1.55%
流通股本
121.21万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
依特钠盘中异动 股价大跌5.26%报1.98美元
自选股智能写手 · 05-03 01:07
依特钠盘中异动 股价大跌5.26%报1.98美元
依特钠盘中异动 快速上涨5.13%报2.05美元
自选股智能写手 · 05-01 21:53
依特钠盘中异动 快速上涨5.13%报2.05美元
依特钠盘中异动 股价大涨6.02%
自选股智能写手 · 05-01
依特钠盘中异动 股价大涨6.02%
依特钠2023财年实现净利润-16.55百万美元,同比增加27.19%
自选股智能写手 · 03-28
依特钠2023财年实现净利润-16.55百万美元,同比增加27.19%
依特钠盘中异动 临近收盘急速上涨5.00%报2.10美元
自选股智能写手 · 03-28
依特钠盘中异动 临近收盘急速上涨5.00%报2.10美元
依特钠盘中异动 快速上涨5.03%
自选股智能写手 · 03-26
依特钠盘中异动 快速上涨5.03%
依特钠盘中异动 股价大涨5.08%报2.07美元
自选股智能写手 · 03-23
依特钠盘中异动 股价大涨5.08%报2.07美元
依特钠盘中异动 早盘急速下跌5.31%
自选股智能写手 · 03-21
依特钠盘中异动 早盘急速下跌5.31%
依特钠盘中异动 股价大跌5.53%报2.05美元
自选股智能写手 · 03-18
依特钠盘中异动 股价大跌5.53%报2.05美元
依特钠盘中异动 早盘急速拉升10.00%
自选股智能写手 · 03-15
依特钠盘中异动 早盘急速拉升10.00%
依特钠盘中异动 早盘股价大跌5.35%
自选股智能写手 · 03-13
依特钠盘中异动 早盘股价大跌5.35%
依特钠盘中异动 下午盘快速上涨6.38%报2.00美元
自选股智能写手 · 03-13
依特钠盘中异动 下午盘快速上涨6.38%报2.00美元
依特钠盘中异动 急速下跌5.13%
自选股智能写手 · 02-28
依特钠盘中异动 急速下跌5.13%
依特钠盘中异动 急速上涨5.52%报1.83美元
自选股智能写手 · 02-24
依特钠盘中异动 急速上涨5.52%报1.83美元
依特钠盘中异动 大幅跳水5.62%报1.68美元
自选股智能写手 · 02-22
依特钠盘中异动 大幅跳水5.62%报1.68美元
依特钠盘中异动 快速跳水5.68%报1.72美元
自选股智能写手 · 02-21
依特钠盘中异动 快速跳水5.68%报1.72美元
依特钠盘中异动 股价大涨6.19%
自选股智能写手 · 02-09
依特钠盘中异动 股价大涨6.19%
依特钠盘中异动 股价大跌5.59%
自选股智能写手 · 02-06
依特钠盘中异动 股价大跌5.59%
依特钠盘中异动 早盘股价大跌5.88%
自选股智能写手 · 02-01
依特钠盘中异动 早盘股价大跌5.88%
加载更多
公司概况
公司名称:
依特钠
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aeterna Zentaris, Inc.于1990年9月12日 ,在Canada Business Corporations Act名下成立,并继续受其管理。Aeterna Zentaris是一家晚期药物的开发公司,专业从事肿瘤学和内分泌治疗。公司产品线包括从开发到销售所有阶段的化合物。公司的主要业务战略是与战略合作伙伴共同进步,其产品开发线上的重点候选产品主要用于肿瘤学和内分泌学领域。此外,该公司还继续推进其他临床和临床前程序,其中一些通过了不同政府机构的授权。公司的愿景是成为一个综合的专业生物制药公司。
发行价格:
--
{"stockData":{"symbol":"AEZS","market":"US","secType":"STK","nameCN":"依特钠","latestPrice":7.74,"timestamp":1714765005819,"preClose":8.16,"halted":0,"volume":18747,"delay":0,"floatShares":1212129,"shares":1213969,"eps":-13.634612,"marketStatus":"交易中","marketStatusCode":2,"change":-0.42,"latestTime":"05-03 15:37:13 EDT","open":7.8,"high":8.3487,"low":7.74,"amount":148085.79623100001,"amplitude":0.074596,"askPrice":7.9,"askSize":210,"bidPrice":7.76,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-13.634612,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714766400000},"split":{"toFactor":1,"forFactor":4,"executeDate":"2024-05-03"},"adr":0,"listingDate":957931200000,"adjPreClose":8.16,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.15,"preClose":2.01,"latestTime":"19:49 EDT","volume":1079,"amount":2329.0431,"timestamp":1714693787522},"volumeRatio":3.049258},"requestUrl":"/m/hq/s/AEZS","defaultTab":"news","newsList":[{"id":"2432052980","title":"依特钠盘中异动 股价大跌5.26%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432052980","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432052980?lang=zh_cn&edition=full","pubTime":"2024-05-03 01:07","pubTimestamp":1714669643,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日01时07分,依特钠股票出现波动,股价急速跳水5.26%。截至发稿,该股报1.98美元/股,成交量1.055万股,换手率0.22%,振幅7.66%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中,整体涨幅为1.06%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030107247925b522&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030107247925b522&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432508202","title":"依特钠盘中异动 快速上涨5.13%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432508202","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432508202?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:53","pubTimestamp":1714571603,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时53分,依特钠股票出现异动,股价快速上涨5.13%。截至发稿,该股报2.05美元/股,成交量4.277万股,换手率0.88%,振幅5.13%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中,整体涨幅为0.36%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012153247a57dc1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012153247a57dc1a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432588614","title":"依特钠盘中异动 股价大涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432588614","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432588614?lang=zh_cn&edition=full","pubTime":"2024-05-01 02:37","pubTimestamp":1714502242,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日02时37分,依特钠股票出现波动,股价快速上涨6.02%。截至发稿,该股报2.07美元/股,成交量8752股,换手率0.18%,振幅2.05%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中,整体涨幅为0.24%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010237227a57ca39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010237227a57ca39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422113867","title":"依特钠2023财年实现净利润-16.55百万美元,同比增加27.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422113867","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422113867?lang=zh_cn&edition=full","pubTime":"2024-03-28 22:11","pubTimestamp":1711635114,"startTime":"0","endTime":"0","summary":"12月31日,依特钠公布财报,公告显示公司2023财年净利润为-16.55百万美元,同比增加27.19%;其中营业收入为4.50百万美元,同比减少20.21%,每股基本收益为-3.41美元。从资产负债表来看,依特钠总负债18.82百万美元,其中短期债务160000.00美元,资产负债比为1.97,流动比率为8.02。机构评级:截至2023年12月31日,当前有1家机构对依特钠目标价做出预测,其中目标均价为15.00美元,其中最低目标价为15.00美元,最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032822115787c10379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032822115787c10379&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422923598","title":"依特钠盘中异动 临近收盘急速上涨5.00%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422923598","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422923598?lang=zh_cn&edition=full","pubTime":"2024-03-28 03:59","pubTimestamp":1711569575,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日03时59分,依特钠股票出现波动,股价急速拉升5.00%。截至发稿,该股报2.10美元/股,成交量2.091万股,换手率0.43%,振幅6.00%。最近的财报数据显示,该股实现营业收入3000.00美元,净利润-4.15百万美元,每股收益-0.85美元,毛利-50000.00美元,市盈率-0.43倍。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中,整体涨幅为0.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328035935791d52f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328035935791d52f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422614597","title":"依特钠盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422614597","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422614597?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:15","pubTimestamp":1711462508,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日22时15分,依特钠股票出现异动,股价大幅上涨5.03%。截至发稿,该股报2.09美元/股,成交量391股,换手率0.01%,振幅1.01%。依特钠股票所在的生物技术行业中,整体跌幅为0.02%。依特钠公司简介:AEterna Zentaris Inc 是一家商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326221508791cfa63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326221508791cfa63&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421827567","title":"依特钠盘中异动 股价大涨5.08%报2.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421827567","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421827567?lang=zh_cn&edition=full","pubTime":"2024-03-23 04:17","pubTimestamp":1711138625,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日04时17分,依特钠股票出现异动,股价大幅上涨5.08%。截至发稿,该股报2.07美元/股,成交量4618股,换手率0.10%,振幅5.12%。最近的财报数据显示,该股实现营业收入3000.00美元,净利润-4.15百万美元,每股收益-0.85美元,毛利-50000.00美元,市盈率-0.43倍。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体跌幅为0.12%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323041705861e081a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323041705861e081a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421414370","title":"依特钠盘中异动 早盘急速下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421414370","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421414370?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:34","pubTimestamp":1711028099,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时34分,依特钠股票出现异动,股价急速下跌5.31%。截至发稿,该股报1.96美元/股,成交量1389股,换手率0.03%,振幅0.00%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体涨幅为0.51%。依特钠公司简介:AEterna Zentaris Inc 是一家商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212134597a4e4096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212134597a4e4096&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420408322","title":"依特钠盘中异动 股价大跌5.53%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420408322","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420408322?lang=zh_cn&edition=full","pubTime":"2024-03-18 22:09","pubTimestamp":1710770960,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日22时09分,依特钠股票出现波动,股价快速跳水5.53%。截至发稿,该股报2.05美元/股,成交量1192股,换手率0.02%,振幅0.00%。最近的财报数据显示,该股实现营业收入3000.00美元,净利润-4.15百万美元,每股收益-0.85美元,毛利-50000.00美元,市盈率-0.45倍。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体涨幅为0.18%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318220920861df1f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318220920861df1f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419797019","title":"依特钠盘中异动 早盘急速拉升10.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419797019","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419797019?lang=zh_cn&edition=full","pubTime":"2024-03-15 22:22","pubTimestamp":1710512560,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日22时22分,依特钠股票出现波动,股价快速上涨10.00%。截至发稿,该股报2.20美元/股,成交量2431股,换手率0.05%,振幅0.78%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体跌幅为0.27%。依特钠公司简介:AEterna Zentaris Inc 是一家商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152222417a4d168a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152222417a4d168a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419635929","title":"依特钠盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419635929","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419635929?lang=zh_cn&edition=full","pubTime":"2024-03-13 22:55","pubTimestamp":1710341734,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日22时55分,依特钠股票出现波动,股价快速下挫5.35%。截至发稿,该股报1.93美元/股,成交量1.4109万股,换手率0.29%,振幅9.56%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体跌幅为0.09%。依特钠公司简介:AEterna Zentaris Inc 是一家商业化和开发治疗和诊断测试的生物制药公司。Aeterna 拥有美国和加拿大以外的 macimorelin 的所有权利。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031322553487e7893b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031322553487e7893b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419566038","title":"依特钠盘中异动 下午盘快速上涨6.38%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419566038","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419566038?lang=zh_cn&edition=full","pubTime":"2024-03-13 02:10","pubTimestamp":1710267024,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日02时10分,依特钠股票出现异动,股价急速拉升6.38%。截至发稿,该股报2.00美元/股,成交量1.6478万股,换手率0.34%,振幅3.72%。最近的财报数据显示,该股实现营业收入3000.00美元,净利润-4.15百万美元,每股收益-0.85美元,毛利-50000.00美元,市盈率-0.41倍。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体涨幅为0.88%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313021024861dd912&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313021024861dd912&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414380661","title":"依特钠盘中异动 急速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414380661","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414380661?lang=zh_cn&edition=full","pubTime":"2024-02-28 04:42","pubTimestamp":1709066562,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日04时42分,依特钠股票出现异动,股价急速下跌5.13%。截至发稿,该股报1.85美元/股,成交量2.3127万股,换手率0.48%,振幅7.69%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体涨幅为0.36%。依特钠公司简介:AEterna Zentaris Inc 是一家商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228044243861d8ec3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228044243861d8ec3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413132337","title":"依特钠盘中异动 急速上涨5.52%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413132337","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413132337?lang=zh_cn&edition=full","pubTime":"2024-02-24 03:49","pubTimestamp":1708717792,"startTime":"0","endTime":"0","summary":"北京时间2024年02月24日03时49分,依特钠股票出现波动,股价大幅拉升5.52%。截至发稿,该股报1.83美元/股,成交量1.6912万股,换手率0.35%,振幅6.92%。依特钠股票所在的生物技术行业中,整体涨幅为0.26%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402240349527a46306e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402240349527a46306e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413217858","title":"依特钠盘中异动 大幅跳水5.62%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413217858","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413217858?lang=zh_cn&edition=full","pubTime":"2024-02-22 22:54","pubTimestamp":1708613641,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日22时54分,依特钠股票出现波动,股价急速跳水5.62%。截至发稿,该股报1.68美元/股,成交量508股,换手率0.01%,振幅0.00%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体涨幅为0.84%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022222540187af741d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022222540187af741d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413486583","title":"依特钠盘中异动 快速跳水5.68%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413486583","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413486583?lang=zh_cn&edition=full","pubTime":"2024-02-21 01:53","pubTimestamp":1708451625,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日01时53分,依特钠股票出现异动,股价大幅下跌5.68%。截至发稿,该股报1.72美元/股,成交量8715股,换手率0.18%,振幅5.48%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体跌幅为0.86%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022101534587e7153a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022101534587e7153a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410205962","title":"依特钠盘中异动 股价大涨6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410205962","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410205962?lang=zh_cn&edition=full","pubTime":"2024-02-09 22:30","pubTimestamp":1707489029,"startTime":"0","endTime":"0","summary":"北京时间2024年02月09日22时30分,依特钠股票出现异动,股价大幅拉升6.19%。截至发稿,该股报1.80美元/股,成交量205股,换手率0.00%,振幅0.00%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体涨幅为0.41%。依特钠公司简介:AEterna Zentaris Inc 是一家商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209223029861d4d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209223029861d4d53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409441432","title":"依特钠盘中异动 股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409441432","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409441432?lang=zh_cn&edition=full","pubTime":"2024-02-06 00:41","pubTimestamp":1707151287,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日00时41分,依特钠股票出现波动,股价大幅下挫5.59%。截至发稿,该股报1.69美元/股,成交量5690股,换手率0.12%,振幅5.03%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。依特钠股票所在的生物技术行业中,整体涨幅为0.59%。依特钠公司简介:AEterna Zentaris Inc 是一家商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060041287a418441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060041287a418441&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408951639","title":"依特钠盘中异动 早盘股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408951639","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408951639?lang=zh_cn&edition=full","pubTime":"2024-02-01 22:30","pubTimestamp":1706797835,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日22时30分,依特钠股票出现异动,股价急速下挫5.88%。截至发稿,该股报1.76美元/股,成交量2股,换手率0.00%,振幅0.00%。依特钠股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Elevai Labs Inc、Kiora Pharmaceuticals Inc、Neurobo Pharmaceuticals Inc涨幅较大,Revelation Biosciences Inc、Kiora Pharmaceuticals Inc、Transcode Therapeutics Inc较为活跃,换手率分别为604.50%、196.16%、176.39%,振幅较大的相关个股有Galecto Inc、Elevai Labs Inc、Neurobo Pharmaceuticals Inc,振幅分别为6.03%、5.79%、4.28%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402012230357a407d68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402012230357a407d68&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zentaris.com","stockEarnings":[{"period":"1week","weight":0.0255},{"period":"1month","weight":-0.0483},{"period":"3month","weight":0.1229},{"period":"6month","weight":0.366},{"period":"1year","weight":-0.2972},{"period":"ytd","weight":0.0806}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0266},{"period":"3month","weight":0.0216},{"period":"6month","weight":0.1618},{"period":"1year","weight":0.2378},{"period":"ytd","weight":0.0625}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aeterna Zentaris, Inc.于1990年9月12日 ,在Canada Business Corporations Act名下成立,并继续受其管理。Aeterna Zentaris是一家晚期药物的开发公司,专业从事肿瘤学和内分泌治疗。公司产品线包括从开发到销售所有阶段的化合物。公司的主要业务战略是与战略合作伙伴共同进步,其产品开发线上的重点候选产品主要用于肿瘤学和内分泌学领域。此外,该公司还继续推进其他临床和临床前程序,其中一些通过了不同政府机构的授权。公司的愿景是成为一个综合的专业生物制药公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.049213},{"month":2,"riseRate":0.458333,"avgChangeRate":0.00928},{"month":3,"riseRate":0.458333,"avgChangeRate":-0.011313},{"month":4,"riseRate":0.541667,"avgChangeRate":0.065619},{"month":5,"riseRate":0.5,"avgChangeRate":0.03339},{"month":6,"riseRate":0.25,"avgChangeRate":-0.078987},{"month":7,"riseRate":0.291667,"avgChangeRate":-0.041037},{"month":8,"riseRate":0.5,"avgChangeRate":-0.039826},{"month":9,"riseRate":0.291667,"avgChangeRate":-0.061538},{"month":10,"riseRate":0.291667,"avgChangeRate":-0.046147},{"month":11,"riseRate":0.5,"avgChangeRate":0.058342},{"month":12,"riseRate":0.5,"avgChangeRate":-0.01243}],"exchange":"NASDAQ","name":"依特钠","nameEN":"AEterna Zentaris"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"依特钠(AEZS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供依特钠(AEZS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"依特钠,AEZS,依特钠股票,依特钠股票老虎,依特钠股票老虎国际,依特钠行情,依特钠股票行情,依特钠股价,依特钠股市,依特钠股票价格,依特钠股票交易,依特钠股票购买,依特钠股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"依特钠(AEZS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供依特钠(AEZS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}